There in my bedroom, in the middle of the night, I saw my 11-year-old daughter clutching her ribs in agony. In the mad dash to hospital, I tried to stay calm, but I was full of fear and ...

A MOTHER has managed to shift over three stone thanks to Mounjaro, but has revealed the five things she wishes she had known ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

In January 2026, the Canadian patent for Ozempic will expire, paving the way for cheap generic versions of the semaglutide ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

Ozempic, which is prescribed for certain adults with type 2 diabetes, can cause side effects. Learn about its potential side effects and how to manage them.

Semaglutide (Ozempic) improves blood sugar control and weight loss in people with type 1 diabetes and obesity using insulin pumps, new study shows.

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like semaglutide (the active ingredient in Ozempic and Wegovy).

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed.

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and similar GLP-1 agonists, but without muscles loss as a potential side ...

Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities ...